IPO Boutique

Ultragenyx Pharmaceutical IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Ultragenyx Pharmaceutical, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Ultragenyx PharmaceuticalRARE -
NASDAQ
$14.00-$17.00 $21.00 $45.805.8 million1/31/2014
J.P. Morgan, Morgan Stanley
Co-Manager(s):
Cowen & Co., Canaccord Genuity
Health Care
Filing(s):

Filed 2013-11-08



Ultragenyx Pharmaceutical Quote & Chart - Click for current quote - RARE

About Ultragenyx Pharmaceutical (adapted from Ultragenyx Pharmaceutical prospectus):
They are a development-stage biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "RARE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved